{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:59:55Z","timestamp":1781650795587,"version":"3.54.5"},"reference-count":232,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Nutr Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Folate is a key regulator of one-carbon metabolism (OCM), which supports essential physiological processes, including DNA synthesis, repair, methylation, amino acid homeostasis, and redox balance. It is also crucial for brain health throughout life, from neural tube formation during early development to neurotransmitter synthesis, myelination, neuronal development, synaptic plasticity and cognitive function during later stages of life. Disruption of folate-mediated OCM (FOCM) can adversely affect brain health and contribute to neurodegeneration. In this review, we summarize current evidence linking FOCM dysregulation to neurodegenerative diseases, emphasizing disease-specific mechanisms and the therapeutic potential of modulating folate metabolism, as evidenced by experimental and clinical studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Disruption of FOCM can lead to oxidative stress, impaired methylation, excitotoxicity, and neuroinflammation, thereby contributing to neurodegenerative diseases. In Alzheimer\u2019s disease, impaired FOCM promotes amyloid-\u03b2 accumulation, tau pathology, cognitive decline, and vascular dysfunction, consistent with low folate and elevated homocysteine observed clinically, though supplementation outcomes remain mixed. In Parkinson\u2019s disease, folate deficiency and hyperhomocysteinemia exacerbate motor deficits and dopaminergic neurodegeneration via oxidative stress, mitochondrial dysfunction, and NLRP3-mediated inflammation and combined folate and vitamin B12 supplementation may reduce levodopa-associated risks. Elevated homocysteine and aberrant FOCM have also been reported in Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and Huntington\u2019s disease and are associated with neuroinflammation, demyelination, neuronal loss, and severe disease phenotypes in these conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Overall, maintaining optimal folate levels may be a promising strategy to support brain health and reduce the risk of neurodegenerative disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13668-026-00761-5","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:19:20Z","timestamp":1777277960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Folate Metabolism in Neurodegenerative Diseases: Insight from Experimental and Clinical Studies"],"prefix":"10.1007","volume":"15","author":[{"given":"Meenakshi","family":"Umar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karson","family":"Franjieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Louise","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisse","family":"Ward-Dones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifudeen","family":"Ismael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose C.","family":"Roskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Courseault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Jaye","family":"Bix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"761_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD. One-Carbon Metabolism in Health and Disease. Cell Metab. 2017;25:27\u201342.","journal-title":"Cell Metab"},{"key":"761_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/nu8020068","volume":"8","author":"DO Kennedy","year":"2016","unstructured":"Kennedy DO. B Vitamins and the Brain: Mechanisms, Dose and Efficacy\u2013A Review. Nutrients. 2016;8:68.","journal-title":"Nutrients"},{"key":"761_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/dneu.22579","volume":"78","author":"OA Balashova","year":"2018","unstructured":"Balashova OA, Visina O, Borodinsky LN. Folate action in nervous system development and disease. Dev Neurobiol. 2018;78:391\u2013402.","journal-title":"Dev Neurobiol"},{"key":"761_CR4","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1073\/pnas.94.7.3290","volume":"94","author":"BC Blount","year":"1997","unstructured":"Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997;94:3290\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"761_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/ebmental-2021-300309","volume":"25","author":"A Rotstein","year":"2022","unstructured":"Rotstein A, Kodesh A, Goldberg Y, Reichenberg A, Levine SZ. Serum folate deficiency and the risks of dementia and all-cause mortality: a national study of old age. Evid Based Ment Health. 2022;25:63\u20138.","journal-title":"Evid Based Ment Health"},{"key":"761_CR6","doi-asserted-by":"publisher","first-page":"665114","DOI":"10.3389\/fnagi.2021.665114","volume":"13","author":"Q Wang","year":"2021","unstructured":"Wang Q, Zhao J, Chang H, Liu X, Zhu R. Homocysteine and Folic Acid: Risk Factors for Alzheimer\u2019s Disease-An Updated Meta-Analysis. Front Aging Neurosci. 2021;13:665114.","journal-title":"Front Aging Neurosci"},{"key":"761_CR7","doi-asserted-by":"publisher","first-page":"1254824","DOI":"10.3389\/fnagi.2023.1254824","volume":"15","author":"Y Quan","year":"2023","unstructured":"Quan Y, Xu J, Xu Q, Guo Z, Ou R, Shang H, Wei Q. Association between the risk and severity of Parkinson\u2019s disease and plasma homocysteine, vitamin B12 and folate levels: a systematic review and meta-analysis. Front Aging Neurosci. 2023;15:1254824.","journal-title":"Front Aging Neurosci"},{"key":"761_CR8","doi-asserted-by":"publisher","first-page":"661198","DOI":"10.3389\/fnins.2021.661198","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang X, Bao G, Liu D, Yang Y, Li X, Cai G, Liu Y, Wu Y. The Association Between Folate and Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis. Front Neurosci. 2021;15:661198.","journal-title":"Front Neurosci"},{"key":"761_CR9","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1001\/archneur.55.11.1449","volume":"55","author":"R Clarke","year":"1998","unstructured":"Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998;55:1449\u201355.","journal-title":"Arch Neurol"},{"key":"761_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3945\/an.112.003392","volume":"4","author":"YM Chan","year":"2013","unstructured":"Chan YM, Bailey R, O\u2019Connor DL. Folate Adv Nutr. 2013;4:123\u20135.","journal-title":"Folate Adv Nutr"},{"key":"761_CR11","first-page":"703","volume":"86","author":"PN Kirke","year":"1993","unstructured":"Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993;86:703\u20138.","journal-title":"Q J Med"},{"key":"761_CR12","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1001\/jama.1993.03500100055027","volume":"269","author":"MM Werler","year":"1993","unstructured":"Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA. 1993;269:1257\u201361.","journal-title":"JAMA"},{"key":"761_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biochi.2015.11.006","volume":"126","author":"DH Alpers","year":"2016","unstructured":"Alpers DH. Absorption and blood\/cellular transport of folate and cobalamin: Pharmacokinetic and physiological considerations. Biochimie. 2016;126:52\u20136.","journal-title":"Biochimie"},{"key":"761_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.nutr.012809.104810","volume":"30","author":"AS Tibbetts","year":"2010","unstructured":"Tibbetts AS, Appling DR. Compartmentalization of Mammalian folate-mediated one-carbon metabolism. Annu Rev Nutr. 2010;30:57\u201381.","journal-title":"Annu Rev Nutr"},{"key":"761_CR15","doi-asserted-by":"publisher","first-page":"nzaa153","DOI":"10.1093\/cdn\/nzaa153","volume":"4","author":"Y Xiu","year":"2020","unstructured":"Xiu Y, Field MS. The Roles of Mitochondrial Folate Metabolism in Supporting Mitochondrial DNA Synthesis, Oxidative Phosphorylation, and Cellular Function. Curr Dev Nutr. 2020;4:nzaa153.","journal-title":"Curr Dev Nutr"},{"key":"761_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-nutr-071714-034441","volume":"38","author":"MS Field","year":"2018","unstructured":"Field MS, Kamynina E, Chon J, Stover PJ. Nuclear Folate Metabolism. Annu Rev Nutr. 2018;38:219\u201343.","journal-title":"Annu Rev Nutr"},{"key":"761_CR17","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1158\/2159-8290.CD-14-1228","volume":"4","author":"I Martinez-Reyes","year":"2014","unstructured":"Martinez-Reyes I, Chandel NS. Mitochondrial one-carbon metabolism maintains redox balance during hypoxia. Cancer Discov. 2014;4:1371\u20133.","journal-title":"Cancer Discov"},{"key":"761_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3945\/an.111.000596","volume":"2","author":"PJ Stover","year":"2011","unstructured":"Stover PJ, Field MS. Trafficking of intracellular folates. Adv Nutr. 2011;2:325\u201331.","journal-title":"Adv Nutr"},{"key":"761_CR19","doi-asserted-by":"crossref","unstructured":"Quadros EV. Folate and other B vitamins in brain health and disease. Nutrients. 2023;15:2525.","DOI":"10.3390\/nu15112525"},{"key":"761_CR20","doi-asserted-by":"crossref","unstructured":"Lionaki E, Ploumi C, Tavernarakis N. One-carbon metabolism: pulling the strings behind aging and neurodegeneration. Cells. 2022;11:214.","DOI":"10.3390\/cells11020214"},{"key":"761_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.reprotox.2018.05.004","volume":"80","author":"JD van Gool","year":"2018","unstructured":"van Gool JD, Hirche H, Lax H, De Schaepdrijver L. Folic acid and primary prevention of neural tube defects: A review. Reprod Toxicol. 2018;80:73\u201384.","journal-title":"Reprod Toxicol"},{"key":"761_CR22","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/cdd.2008.64","volume":"15","author":"F Cecconi","year":"2008","unstructured":"Cecconi F, Piacentini M, Fimia GM. The involvement of cell death and survival in neural tube defects: a distinct role for apoptosis and autophagy? Cell Death Differ. 2008;15:1170\u20137.","journal-title":"Cell Death Differ"},{"key":"761_CR23","doi-asserted-by":"crossref","unstructured":"Sudiwala S, Palmer A, Massa V, Burns AJ, Dunlevy LPE, de Castro SCP, Savery D, Leung KY, Copp AJ, Greene NDE. Cellular mechanisms underlying Pax3-related neural tube defects and their prevention by folic acid. Dis Model Mech. 2019;12:dmm042234.","DOI":"10.1242\/dmm.042234"},{"key":"761_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2015.04.067","volume":"300","author":"NM Jadavji","year":"2015","unstructured":"Jadavji NM, Deng L, Malysheva O, Caudill MA, Rozen R. MTHFR deficiency or reduced intake of folate or choline in pregnant mice results in impaired short-term memory and increased apoptosis in the hippocampus of wild-type offspring. Neuroscience. 2015;300:1\u20139.","journal-title":"Neuroscience"},{"key":"761_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jama.2023.12876","volume":"330","author":"USPST Force","year":"2023","unstructured":"Force USPST, Barry MJ, Nicholson WK, Silverstein M, Chelmow D, Coker TR, Davis EM, Donahue KE, Jaen CR, Li L, et al. Folic Acid Supplementation to Prevent Neural Tube Defects: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2023;330:454\u20139.","journal-title":"JAMA"},{"key":"761_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1017\/S0029665114001554","volume":"74","author":"C McGarel","year":"2015","unstructured":"McGarel C, Pentieva K, Strain JJ, McNulty H. Emerging roles for folate and related B-vitamins in brain health across the lifecycle. Proc Nutr Soc. 2015;74:46\u201355.","journal-title":"Proc Nutr Soc"},{"key":"761_CR27","doi-asserted-by":"publisher","first-page":"S2356","DOI":"10.1093\/jn\/132.8.2356S","volume":"132","author":"NS Green","year":"2002","unstructured":"Green NS. Folic acid supplementation and prevention of birth defects. J Nutr. 2002;132:S2356\u201360.","journal-title":"J Nutr"},{"key":"761_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1515\/cclm-2012-0673","volume":"51","author":"SH Kirsch","year":"2013","unstructured":"Kirsch SH, Herrmann W, Obeid R. Genetic defects in folate and cobalamin pathways affecting the brain. Clin Chem Lab Med. 2013;51:139\u201355.","journal-title":"Clin Chem Lab Med"},{"key":"761_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0950-3536(05)80222-7","volume":"8","author":"J Zittoun","year":"1995","unstructured":"Zittoun J. Congenital errors of folate metabolism. Baillieres Clin Haematol. 1995;8:603\u201316.","journal-title":"Baillieres Clin Haematol"},{"key":"761_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mam.2016.09.002","volume":"53","author":"R Zhao","year":"2017","unstructured":"Zhao R, Aluri S, Goldman ID. The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption. Mol Aspects Med. 2017;53:57\u201372.","journal-title":"Mol Aspects Med"},{"key":"761_CR31","unstructured":"Goldman ID. FOLR1-Related Cerebral Folate Transport Deficiency. In GeneReviews((R)), Adam, M P, Feldman, J, Mirzaa, G M, Pagon, R A, Wallace, S E, Amemiya, A, Eds. Seattle (WA), 1993."},{"key":"761_CR32","doi-asserted-by":"crossref","unstructured":"Ramaekers VT, Quadros EV. Cerebral folate deficiency syndrome: early diagnosis, intervention and treatment strategies. Nutrients. 2022;14:3096.","DOI":"10.3390\/nu14153096"},{"key":"761_CR33","doi-asserted-by":"crossref","unstructured":"Rossignol DA, Frye RE. Cerebral folate deficiency, folate receptor alpha autoantibodies and leucovorin (folinic acid) treatment in autism spectrum disorders: a systematic review and meta-analysis. J Pers Med. 2021;11:1141.","DOI":"10.3390\/jpm11111141"},{"key":"761_CR34","doi-asserted-by":"publisher","first-page":"100835","DOI":"10.1016\/j.spen.2020.100835","volume":"35","author":"RE Frye","year":"2020","unstructured":"Frye RE, Rossignol DA, Scahill L, McDougle CJ, Huberman H, Quadros EV. Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder. Semin Pediatr Neurol. 2020;35:100835.","journal-title":"Semin Pediatr Neurol"},{"key":"761_CR35","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1007\/s00431-024-05762-6","volume":"183","author":"PK Panda","year":"2024","unstructured":"Panda PK, Sharawat IK, Saha S, Gupta D, Palayullakandi A, Meena K. Efficacy of oral folinic acid supplementation in children with autism spectrum disorder: a randomized double-blind, placebo-controlled trial. Eur J Pediatr. 2024;183:4827\u201335.","journal-title":"Eur J Pediatr"},{"key":"761_CR36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapsychiatry.2017.4050","volume":"75","author":"SZ Levine","year":"2018","unstructured":"Levine SZ, Kodesh A, Viktorin A, Smith L, Uher R, Reichenberg A, Sandin S. Association of Maternal Use of Folic Acid and Multivitamin Supplements in the Periods Before and During Pregnancy With the Risk of Autism Spectrum Disorder in Offspring. JAMA Psychiatry. 2018;75:176\u201384.","journal-title":"JAMA Psychiatry"},{"key":"761_CR37","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s10803-021-05110-9","volume":"52","author":"KK Brieger","year":"2022","unstructured":"Brieger KK, Bakulski KM, Pearce CL, Baylin A, Dou JF, Feinberg JI, Croen LA, Hertz-Picciotto I, Newschaffer CJ, Fallin MD, et al. The Association of Prenatal Vitamins and Folic Acid Supplement Intake with Odds of Autism Spectrum Disorder in a High-Risk Sibling Cohort, the Early Autism Risk Longitudinal Investigation (EARLI). J Autism Dev Disord. 2022;52:2801\u201311.","journal-title":"J Autism Dev Disord"},{"key":"761_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/ppe.12414","volume":"32","author":"R Raghavan","year":"2018","unstructured":"Raghavan R, Riley AW, Volk H, Caruso D, Hironaka L, Sices L, Hong X, Wang G, Ji Y, Brucato M, et al. Maternal Multivitamin Intake, Plasma Folate and Vitamin B(12) Levels and Autism Spectrum Disorder Risk in Offspring. Paediatr Perinat Epidemiol. 2018;32:100\u201311.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"761_CR39","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1097\/WNR.0000000000000887","volume":"28","author":"L Gao","year":"2017","unstructured":"Gao L, Liu X, Yu L, Wu J, Xu M, Liu Y. Folic acid exerts antidepressant effects by upregulating brain-derived neurotrophic factor and glutamate receptor 1 expression in brain. NeuroReport. 2017;28:1078\u201384.","journal-title":"NeuroReport"},{"key":"761_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuroscience.2013.04.014","volume":"245","author":"S Eckart","year":"2013","unstructured":"Eckart S, Hortnagl H, Kronenberg G, Gertz K, Horster H, Endres M, Hellweg R. Reduced nerve growth factor levels in stress-related brain regions of folate-deficient mice. Neuroscience. 2013;245:129\u201335.","journal-title":"Neuroscience"},{"key":"761_CR41","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"11","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci. 2015;11:1164\u201378.","journal-title":"Arch Med Sci"},{"key":"761_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/dneu.20774","volume":"70","author":"S Cohen-Cory","year":"2010","unstructured":"Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol. 2010;70:271\u201388.","journal-title":"Dev Neurobiol"},{"key":"761_CR43","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2174\/1570159X16666180412092859","volume":"16","author":"ML Rocco","year":"2018","unstructured":"Rocco ML, Soligo M, Manni L, Aloe L. Nerve Growth Factor: Early Studies and Recent Clinical Trials. Curr Neuropharmacol. 2018;16:1455\u201365.","journal-title":"Curr Neuropharmacol"},{"key":"761_CR44","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00213-012-2643-y","volume":"222","author":"XY Zhang","year":"2012","unstructured":"Zhang XY, Liang J, Chen DC, Xiu MH, Yang FD, Kosten TA, Kosten TR. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology. 2012;222:277\u201384.","journal-title":"Psychopharmacology"},{"key":"761_CR45","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.psychres.2019.01.051","volume":"273","author":"Y Yang","year":"2019","unstructured":"Yang Y, Liu Y, Wang G, Hei G, Wang X, Li R, Li L, Wu R, Zhao J. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia. Psychiatry Res. 2019;273:528\u201336.","journal-title":"Psychiatry Res"},{"key":"761_CR46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/1673-5374.243718","volume":"14","author":"WB Kang","year":"2019","unstructured":"Kang WB, Chen YJ, Lu DY, Yan JZ. Folic acid contributes to peripheral nerve injury repair by promoting Schwann cell proliferation, migration, and secretion of nerve growth factor. Neural Regen Res. 2019;14:132\u20139.","journal-title":"Neural Regen Res"},{"key":"761_CR47","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.4088\/JCP.v69n0901","volume":"69","author":"SM Stahl","year":"2008","unstructured":"Stahl SM. L-methylfolate: a vitamin for your monoamines. J Clin Psychiatry. 2008;69:1352\u20133.","journal-title":"J Clin Psychiatry"},{"key":"761_CR48","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1054-3589(08)60806-6","volume":"42","author":"DS Goldstein","year":"1998","unstructured":"Goldstein DS. Catecholamines in the periphery. Overview. Adv Pharmacol. 1998;42:529\u201339.","journal-title":"Adv Pharmacol"},{"key":"761_CR49","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrneurol.2015.172","volume":"11","author":"J Ng","year":"2015","unstructured":"Ng J, Papandreou A, Heales SJ, Kurian MA. Monoamine neurotransmitter disorders\u2013clinical advances and future perspectives. Nat Rev Neurol. 2015;11:567\u201384.","journal-title":"Nat Rev Neurol"},{"key":"761_CR50","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1017\/S0033291700038447","volume":"22","author":"T Bottiglieri","year":"1992","unstructured":"Bottiglieri T, Hyland K, Laundy M, Godfrey P, Carney MW, Toone BK, Reynolds EH. Folate deficiency, biopterin and monoamine metabolism in depression. Psychol Med. 1992;22:871\u20136.","journal-title":"Psychol Med"},{"key":"761_CR51","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41598-017-01732-1","volume":"7","author":"Q Weng","year":"2017","unstructured":"Weng Q, Wang J, Wang J, Tan B, Wang J, Wang H, Zheng T, Lu QR, Yang B, He Q. Folate Metabolism Regulates Oligodendrocyte Survival and Differentiation by Modulating AMPKalpha Activity. Sci Rep. 2017;7:1705.","journal-title":"Sci Rep"},{"key":"761_CR52","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1212\/01.WNL.0000152840.26156.74","volume":"64","author":"M Linnebank","year":"2005","unstructured":"Linnebank M, Pels H, Kleczar N, Farmand S, Fliessbach K, Urbach H, Orlopp K, Klockgether T, Schmidt-Wolf IG, Schlegel U. MTX-induced white matter changes are associated with polymorphisms of methionine metabolism. Neurology. 2005;64:912\u20133.","journal-title":"Neurology"},{"key":"761_CR53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jnutbio.2007.02.004","volume":"19","author":"CM Abratte","year":"2008","unstructured":"Abratte CM, Wang W, Li R, Moriarty DJ, Caudill MA. Folate intake and the MTHFR C677T genotype influence choline status in young Mexican American women. J Nutr Biochem. 2008;19:158\u201365.","journal-title":"J Nutr Biochem"},{"key":"761_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/nutrit\/nuw053","volume":"75","author":"AE Stanhewicz","year":"2017","unstructured":"Stanhewicz AE, Kenney WL. Role of folic acid in nitric oxide bioavailability and vascular endothelial function. Nutr Rev. 2017;75:61\u201370.","journal-title":"Nutr Rev"},{"key":"761_CR55","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.yjmcc.2009.07.025","volume":"47","author":"L Gao","year":"2009","unstructured":"Gao L, Chalupsky K, Stefani E, Cai H. Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity. J Mol Cell Cardiol. 2009;47:752\u201360.","journal-title":"J Mol Cell Cardiol"},{"key":"761_CR56","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1089\/ars.2015.6329","volume":"23","author":"K Chalupsky","year":"2015","unstructured":"Chalupsky K, Kracun D, Kanchev I, Bertram K, Gorlach A. Folic Acid Promotes Recycling of Tetrahydrobiopterin and Protects Against Hypoxia-Induced Pulmonary Hypertension by Recoupling Endothelial Nitric Oxide Synthase. Antioxid Redox Signal. 2015;23:1076\u201391.","journal-title":"Antioxid Redox Signal"},{"key":"761_CR57","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3892\/mmr.2014.2332","volume":"10","author":"M Zhang","year":"2014","unstructured":"Zhang M, Wen J, Wang X, Xiao C. High\u2013dose folic acid improves endothelial function by increasing tetrahydrobiopterin and decreasing homocysteine levels. Mol Med Rep. 2014;10:1609\u201313.","journal-title":"Mol Med Rep"},{"key":"761_CR58","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/S0735-1097(99)00469-6","volume":"34","author":"KS Woo","year":"1999","unstructured":"Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol. 1999;34:2002\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"761_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12937-023-00843-y","volume":"22","author":"M Zamani","year":"2023","unstructured":"Zamani M, Rezaiian F, Saadati S, Naseri K, Ashtary-Larky D, Yousefi M, Golalipour E, Clark CCT, Rastgoo S, Asbaghi O. The effects of folic acid supplementation on endothelial function in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Nutr J. 2023;22:12.","journal-title":"Nutr J"},{"key":"761_CR60","doi-asserted-by":"publisher","first-page":"15424","DOI":"10.1073\/pnas.0902072106","volume":"106","author":"SW Bailey","year":"2009","unstructured":"Bailey SW, Ayling JE. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci U S A. 2009;106:15424\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"761_CR61","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10545-011-9418-1","volume":"35","author":"D Watkins","year":"2012","unstructured":"Watkins D, Rosenblatt DS. Update and new concepts in vitamin responsive disorders of folate transport and metabolism. J Inherit Metab Dis. 2012;35:665\u201370.","journal-title":"J Inherit Metab Dis"},{"key":"761_CR62","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ijdevneu.2005.05.007","volume":"23","author":"Z Chen","year":"2005","unstructured":"Chen Z, Schwahn BC, Wu Q, He X, Rozen R. Postnatal cerebellar defects in mice deficient in methylenetetrahydrofolate reductase. Int J Dev Neurosci. 2005;23:465\u201374.","journal-title":"Int J Dev Neurosci"},{"key":"761_CR63","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/hmg\/10.5.433","volume":"10","author":"Z Chen","year":"2001","unstructured":"Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Chen MF, Pai A, John SW, Smith RS, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet. 2001;10:433\u201343.","journal-title":"Hum Mol Genet"},{"key":"761_CR64","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ymgme.2012.03.020","volume":"106","author":"NM Jadavji","year":"2012","unstructured":"Jadavji NM, Deng L, Leclerc D, Malysheva O, Bedell BJ, Caudill MA, Rozen R. Severe methylenetetrahydrofolate reductase deficiency in mice results in behavioral anomalies with morphological and biochemical changes in hippocampus. Mol Genet Metab. 2012;106:149\u201359.","journal-title":"Mol Genet Metab"},{"key":"761_CR65","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/BJ20131568","volume":"461","author":"NM Jadavji","year":"2014","unstructured":"Jadavji NM, Bahous RH, Deng L, Malysheva O, Grand\u2019maison M, Bedell BJ, Caudill MA, Rozen R. Mouse model for deficiency of methionine synthase reductase exhibits short-term memory impairment and disturbances in brain choline metabolism. Biochem J. 2014;461:205\u201312.","journal-title":"Biochem J"},{"key":"761_CR66","doi-asserted-by":"crossref","unstructured":"Sobral AF, Cunha A, Silva V, Gil-Martins E, Silva R, Barbosa DJ. Unveiling the therapeutic potential of folate-dependent one-carbon metabolism in cancer and neurodegeneration. Int J Mol Sci. 2024;25:9339.","DOI":"10.3390\/ijms25179339"},{"key":"761_CR67","doi-asserted-by":"publisher","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","volume":"20","author":"II Kruman","year":"2000","unstructured":"Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci. 2000;20:6920\u20136.","journal-title":"J Neurosci"},{"key":"761_CR68","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","volume":"94","author":"SA Lipton","year":"1997","unstructured":"Lipton SA, Kim WK, Choi YB, Kumar S, D\u2019Emilia DM, Rayudu PV, Arnelle DR, Stamler JS. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 1997;94:5923\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"761_CR69","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1471-4159.2009.06207.x","volume":"110","author":"R Poddar","year":"2009","unstructured":"Poddar R, Paul S. Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J Neurochem. 2009;110:1095\u2013106.","journal-title":"J Neurochem"},{"key":"761_CR70","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/jnc.12102","volume":"124","author":"R Poddar","year":"2013","unstructured":"Poddar R, Paul S. Novel crosstalk between ERK MAPK and p38 MAPK leads to homocysteine-NMDA receptor-mediated neuronal cell death. J Neurochem. 2013;124:558\u201370.","journal-title":"J Neurochem"},{"key":"761_CR71","doi-asserted-by":"crossref","unstructured":"Moretti R, Caruso P. The controversial role of homocysteine in neurology: from labs to clinical practice. Int J Mol Sci. 2019;20:231.","DOI":"10.3390\/ijms20010231"},{"key":"761_CR72","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","volume":"580","author":"R Obeid","year":"2006","unstructured":"Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 2006;580:2994\u20133005.","journal-title":"FEBS Lett"},{"key":"761_CR73","doi-asserted-by":"crossref","unstructured":"Esse R, Barroso M, Tavares de Almeida I, Castro R. The contribution of homocysteine metabolism disruption to endothelial dysfunction: state-of-the-art. Int J Mol Sci. 2019;20:867.","DOI":"10.3390\/ijms20040867"},{"key":"761_CR74","doi-asserted-by":"publisher","first-page":"17012","DOI":"10.1074\/jbc.272.27.17012","volume":"272","author":"GR Upchurch Jr","year":"1997","unstructured":"Upchurch GR Jr., Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr., Loscalzo J. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem. 1997;272:17012\u20137.","journal-title":"J Biol Chem"},{"key":"761_CR75","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0969-9961(03)00070-6","volume":"14","author":"PI Ho","year":"2003","unstructured":"Ho PI, Ashline D, Dhitavat S, Ortiz D, Collins SC, Shea TB, Rogers E. Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol Dis. 2003;14:32\u201342.","journal-title":"Neurobiol Dis"},{"key":"761_CR76","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0891-5849(02)01001-8","volume":"33","author":"TB Shea","year":"2002","unstructured":"Shea TB, Rogers E, Ashline D, Ortiz D, Sheu MS. Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. Free Radic Biol Med. 2002;33:1115\u201320.","journal-title":"Free Radic Biol Med"},{"key":"761_CR77","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang J, Wang Z, Ren Q, Li Z, Huang G, Li W. Folic acid ameliorates neuronal ferroptosis in aging by up-regulating SLC7A11-GSH-GPX(4) antioxidant pathway and increasing cystine levels. Int J Mol Sci. 2025;26:6669.","DOI":"10.3390\/ijms26146669"},{"key":"761_CR78","doi-asserted-by":"publisher","first-page":"34051","DOI":"10.1038\/srep34051","volume":"6","author":"S Do Carmo","year":"2016","unstructured":"Do Carmo S, Hanzel CE, Jacobs ML, Machnes Z, Iulita MF, Yang J, Yu L, Ducatenzeiler A, Danik M, Breuillaud LS, et al. Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer\u2019s Model. Sci Rep. 2016;6:34051.","journal-title":"Sci Rep"},{"key":"761_CR79","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3233\/JAD-2009-1012","volume":"16","author":"F Panza","year":"2009","unstructured":"Panza F, Frisardi V, Capurso C, D\u2019Introno A, Colacicco AM, Vendemiale G, Capurso A, Solfrizzi V. Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer\u2019s disease. J Alzheimers Dis. 2009;16:467\u201370.","journal-title":"J Alzheimers Dis"},{"key":"761_CR80","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12974-017-0963-x","volume":"14","author":"S Chen","year":"2017","unstructured":"Chen S, Dong Z, Cheng M, Zhao Y, Wang M, Sai N, Wang X, Liu H, Huang G, Zhang X. Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke. J Neuroinflammation. 2017;14:187.","journal-title":"J Neuroinflammation"},{"key":"761_CR81","doi-asserted-by":"publisher","first-page":"137264","DOI":"10.1016\/j.neulet.2023.137264","volume":"807","author":"A Shaikh","year":"2023","unstructured":"Shaikh A, Roy H. Folate deprivation induced neuroinflammation impairs cognition. Neurosci Lett. 2023;807:137264.","journal-title":"Neurosci Lett"},{"key":"761_CR82","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","volume":"80","author":"W Duan","year":"2002","unstructured":"Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson\u2019s disease. J Neurochem. 2002;80:101\u201310.","journal-title":"J Neurochem"},{"key":"761_CR83","doi-asserted-by":"publisher","first-page":"102481","DOI":"10.1016\/j.arr.2024.102481","volume":"101","author":"PT Kamatham","year":"2024","unstructured":"Kamatham PT, Shukla R, Khatri DK, Vora LK. Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: Breaking the memory barrier. Ageing Res Rev. 2024;101:102481.","journal-title":"Ageing Res Rev"},{"key":"761_CR84","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71:505\u20138.","journal-title":"JAMA Neurol"},{"key":"761_CR85","doi-asserted-by":"crossref","unstructured":"Mielech A, Puscion-Jakubik A, Markiewicz-Zukowska R, Socha K. Vitamins in Alzheimer\u2019s disease-review of the latest reports. Nutrients. 2020;12:3458.","DOI":"10.3390\/nu12113458"},{"key":"761_CR86","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2147\/CIA.S27983","volume":"8","author":"BR Cardoso","year":"2013","unstructured":"Cardoso BR, Cominetti C, Cozzolino SM. Importance and management of micronutrient deficiencies in patients with Alzheimer\u2019s disease. Clin Interv Aging. 2013;8:531\u201342.","journal-title":"Clin Interv Aging"},{"key":"761_CR87","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/ajcn\/82.3.636","volume":"82","author":"G Ravaglia","year":"2005","unstructured":"Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005;82:636\u201343.","journal-title":"Am J Clin Nutr"},{"key":"761_CR88","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshadri","year":"2002","unstructured":"Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D\u2019Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease. N Engl J Med. 2002;346:476\u201383.","journal-title":"N Engl J Med"},{"key":"761_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0004-282X2005000100001","volume":"63","author":"LL Fernandez","year":"2005","unstructured":"Fernandez LL, Scheibe RM. Is MTHFR polymorphism a risk factor for Alzheimer\u2019s disease like APOE? Arq Neuropsiquiatr. 2005;63:1\u20136.","journal-title":"Arq Neuropsiquiatr"},{"key":"761_CR90","doi-asserted-by":"publisher","first-page":"11352","DOI":"10.18632\/aging.202827","volume":"13","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Xiao X, Wen Y, Wan M, Zhou L, Liu X, Wang X, Guo L, Liu H, Zhou Y, et al. Genetic effect of MTHFR C677T, A1298C, and A1793G polymorphisms on the age at onset, plasma homocysteine, and white matter lesions in Alzheimer\u2019s disease in the Chinese population. Aging. 2021;13:11352\u201362.","journal-title":"Aging"},{"key":"761_CR91","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1515\/med-2019-0006","volume":"14","author":"J Yi","year":"2019","unstructured":"Yi J, Xiao L, Zhou SQ, Zhang WJ, Liu BY. The C677T Polymorphism of the Methylenetetrahydrofolate Reductase Gene and Susceptibility to Late-onset Alzheimer\u2019s Disease. Open Med (Wars). 2019;14:32\u201340.","journal-title":"Open Med (Wars)"},{"key":"761_CR92","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neulet.2014.11.049","volume":"586","author":"Q Peng","year":"2015","unstructured":"Peng Q, Lao X, Huang X, Qin X, Li S, Zeng Z. The MTHFR C677T polymorphism contributes to increased risk of Alzheimer\u2019s disease: evidence based on 40 case-control studies. Neurosci Lett. 2015;586:36\u201342.","journal-title":"Neurosci Lett"},{"key":"761_CR93","doi-asserted-by":"publisher","first-page":"101421","DOI":"10.1016\/j.arr.2021.101421","volume":"71","author":"GNSH Marise","year":"2021","unstructured":"Marise GNSH, Satish VLP, Yergolkar KS, Krishnamurthy AV, Ganesan Rajalekshmi M, Radhika S, Burri K. Untangling huge literature to disinter genetic underpinnings of Alzheimer\u2019s Disease: A systematic review and meta-analysis. Ageing Res Rev. 2021;71:101421.","journal-title":"Ageing Res Rev"},{"key":"761_CR94","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neures.2010.06.011","volume":"68","author":"MY Zhang","year":"2010","unstructured":"Zhang MY, Miao L, Li YS, Hu GY. Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to Alzheimer\u2019s disease. Neurosci Res. 2010;68:142\u201350.","journal-title":"Neurosci Res"},{"key":"761_CR95","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111\u20133.","journal-title":"Nat Genet"},{"key":"761_CR96","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/01616412.2017.1297340","volume":"39","author":"S Liu","year":"2017","unstructured":"Liu S, Wu Y, Liu X, Zhou J, Wang Z, He Z, Huang Z. Lack of association between MTHFR A1298C variant and Alzheimer\u2019s disease: evidence from a systematic review and cumulative meta-analysis. Neurol Res. 2017;39:426\u201334.","journal-title":"Neurol Res"},{"key":"761_CR97","doi-asserted-by":"publisher","first-page":"e10031","DOI":"10.1016\/j.neurobiolaging.2011.09.018","volume":"33","author":"N Mansoori","year":"2012","unstructured":"Mansoori N, Tripathi M, Luthra K, Alam R, Lakshmy R, Sharma S, Arulselvi S, Parveen S, Mukhopadhyay AK. MTHFR (677 and 1298) and IL-6-174 G\/C genes in pathogenesis of Alzheimer\u2019s and vascular dementia and their epistatic interaction. Neurobiol Aging. 2012;33:e10031\u20138.","journal-title":"Neurobiol Aging"},{"key":"761_CR98","doi-asserted-by":"crossref","unstructured":"Miyan J, Buttercase C, Beswick E, Miyan S, Moshkdanian G, Naz N. Folate related pathway gene analysis reveals a novel metabolic variant associated with Alzheimer\u2019s disease with a change in metabolic profile. Metabolites. 2022;12:475.","DOI":"10.3390\/metabo12060475"},{"key":"761_CR99","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00702-010-0383-x","volume":"117","author":"XH Bi","year":"2010","unstructured":"Bi XH, Zhao HL, Zhang ZX, Liu Q, Zhang JW. Association analysis of CbetaS 844ins68 and MTHFD1 G1958A polymorphisms with Alzheimer\u2019s disease in Chinese. J Neural Transm (Vienna). 2010;117:499\u2013503.","journal-title":"J Neural Transm (Vienna)"},{"key":"761_CR100","doi-asserted-by":"publisher","first-page":"e1001130","DOI":"10.1371\/journal.pgen.1001130","volume":"6","author":"AC Naj","year":"2010","unstructured":"Naj AC, Beecham GW, Martin ER, Gallins PJ, Powell EH, Konidari I, Whitehead PL, Cai G, Haroutunian V, Scott WK, et al. Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLoS Genet. 2010;6:e1001130.","journal-title":"PLoS Genet"},{"key":"761_CR101","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jns.2011.06.036","volume":"308","author":"RJ Ren","year":"2011","unstructured":"Ren RJ, Wang LL, Fang R, Liu LH, Wang Y, Tang HD, Deng YL, Xu W, Wang G, Chen SD. The MTHFD1L gene rs11754661 marker is associated with susceptibility to Alzheimer\u2019s disease in the Chinese Han population. J Neurol Sci. 2011;308:32\u20134.","journal-title":"J Neurol Sci"},{"key":"761_CR102","doi-asserted-by":"publisher","first-page":"111071","DOI":"10.1016\/j.pnpbp.2024.111071","volume":"134","author":"Y Tang","year":"2024","unstructured":"Tang Y, Zhou X, Cao J, Li Z, Yin W, Wan K, Huang C, Zhu W, Yin J, Zhang W, et al. Synergistic effect of folate and MTHFR C677T on hippocampal subfields and perfusion in Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2024;134:111071.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"761_CR103","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/jnc.13766","volume":"139","author":"A Oikonomidi","year":"2016","unstructured":"Oikonomidi A, Lewczuk P, Kornhuber J, Smulders Y, Linnebank M, Semmler A, Popp J. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta. J Neurochem. 2016;139:324\u201332.","journal-title":"J Neurochem"},{"key":"761_CR104","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1001\/jama.300.15.1774","volume":"300","author":"PS Aisen","year":"2008","unstructured":"Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, et al. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA. 2008;300:1774\u201383.","journal-title":"JAMA"},{"key":"761_CR105","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clnu.2010.12.004","volume":"30","author":"T Kwok","year":"2011","unstructured":"Kwok T, Lee J, Law CB, Pan PC, Yung CY, Choi KC, Lam LC. A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people. Clin Nutr. 2011;30:297\u2013302.","journal-title":"Clin Nutr"},{"key":"761_CR106","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1532-5415.2009.02217.x","volume":"57","author":"E Richard","year":"2009","unstructured":"Richard E, Kuiper R, Dijkgraaf MG, Van Gool WA. Evaluation of Vascular care in Alzheimer\u2019s d. Vascular care in patients with Alzheimer\u2019s disease with cerebrovascular lesions-a randomized clinical trial. J Am Geriatr Soc. 2009;57:797\u2013805.","journal-title":"J Am Geriatr Soc"},{"key":"761_CR107","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3233\/JAD-160241","volume":"54","author":"WR Shankle","year":"2016","unstructured":"Shankle WR, Hara J, Barrentine LW, Curole MV. CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer\u2019s Disease and Cerebrovascular Disease. J Alzheimers Dis. 2016;54:1073\u201384.","journal-title":"J Alzheimers Dis"},{"key":"761_CR108","doi-asserted-by":"publisher","first-page":"5912146","DOI":"10.1155\/2016\/5912146","volume":"2016","author":"H Chen","year":"2016","unstructured":"Chen H, Liu S, Ji L, Wu T, Ji Y, Zhou Y, Zheng M, Zhang M, Xu W, Huang G. Folic Acid Supplementation Mitigates Alzheimer\u2019s Disease by Reducing Inflammation: A Randomized Controlled Trial. Mediators Inflamm. 2016;2016:5912146.","journal-title":"Mediators Inflamm"},{"key":"761_CR109","doi-asserted-by":"publisher","first-page":"249","DOI":"10.14283\/jpad.2021.22","volume":"8","author":"H Chen","year":"2021","unstructured":"Chen H, Liu S, Ge B, Zhou D, Li M, Li W, Ma F, Liu Z, Ji Y, Huang G. Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer\u2019s Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial. J Prev Alzheimers Dis. 2021;8:249\u201356.","journal-title":"J Prev Alzheimers Dis"},{"key":"761_CR110","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JAD-142499","volume":"45","author":"R Remington","year":"2015","unstructured":"Remington R, Bechtel C, Larsen D, Samar A, Doshanjh L, Fishman P, Luo Y, Smyers K, Page R, Morrell C, et al. A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer\u2019s Disease. J Alzheimers Dis. 2015;45:395\u2013405.","journal-title":"J Alzheimers Dis"},{"key":"761_CR111","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3233\/JAD-151098","volume":"51","author":"R Remington","year":"2016","unstructured":"Remington R, Bechtel C, Larsen D, Samar A, Page R, Morrell C, Shea TB. Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer\u2019s Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study. J Alzheimers Dis. 2016;51:991\u20135.","journal-title":"J Alzheimers Dis"},{"key":"761_CR112","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3233\/JAD-130575","volume":"37","author":"K Ito","year":"2013","unstructured":"Ito K, Corrigan B, Romero K, Anziano R, Neville J, Stephenson D, Lalonde R. Understanding placebo responses in Alzheimer\u2019s disease clinical trials from the literature meta-data and CAMD database. J Alzheimers Dis. 2013;37:173\u201383.","journal-title":"J Alzheimers Dis"},{"key":"761_CR113","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1523\/JNEUROSCI.22-05-01752.2002","volume":"22","author":"II Kruman","year":"2002","unstructured":"Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer\u2019s disease. J Neurosci. 2002;22:1752\u201362.","journal-title":"J Neurosci"},{"key":"761_CR114","doi-asserted-by":"publisher","unstructured":"Crivello N, Spires-Jones T, Shukitt-Hale B, Carey A, Roe A, Smith D, Blusztajn JK, Hyman B, Rosenberg I. Folate deficiency accelerates Alzheimer\u2019s disease related pathology in APP\/PS1 mice. Faseb J. 2013;27:1077.8. https:\/\/doi.org\/10.1096\/fasebj.27.1_supplement.1077.8.","DOI":"10.1096\/fasebj.27.1_supplement.1077.8"},{"key":"761_CR115","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jnutbio.2015.03.009","volume":"26","author":"W Li","year":"2015","unstructured":"Li W, Liu H, Yu M, Zhang X, Zhang M, Wilson JX, Huang G. Folic acid administration inhibits amyloid beta-peptide accumulation in APP\/PS1 transgenic mice. J Nutr Biochem. 2015;26:883\u201391.","journal-title":"J Nutr Biochem"},{"key":"761_CR116","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1007\/s12035-018-1375-3","volume":"56","author":"RH Bahous","year":"2019","unstructured":"Bahous RH, Cosin-Tomas M, Deng L, Leclerc D, Malysheva O, Ho MK, Pallas M, Kaliman P, Bedell BJ, Caudill MA, et al. Early Manifestations of Brain Aging in Mice Due to Low Dietary Folate and Mild MTHFR Deficiency. Mol Neurobiol. 2019;56:4175\u201391.","journal-title":"Mol Neurobiol"},{"key":"761_CR117","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0271678X221122644","volume":"42","author":"AM Reagan","year":"2022","unstructured":"Reagan AM, Christensen KE, Graham LC, Bedwell AA, Eldridge K, Speedy R, Figueiredo LL, Persohn SC, Bottiglieri T, Nho K, et al. The 677C\u2009>\u2009T variant in methylenetetrahydrofolate reductase causes morphological and functional cerebrovascular deficits in mice. J Cereb Blood Flow Metab. 2022;42:2333\u201350.","journal-title":"J Cereb Blood Flow Metab"},{"key":"761_CR118","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X. Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell. 2025;16:83\u2013120.","journal-title":"Protein Cell"},{"key":"761_CR119","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","volume":"57","author":"R Rajmohan","year":"2017","unstructured":"Rajmohan R, Reddy PH. Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer\u2019s disease Neurons. J Alzheimers Dis. 2017;57:975\u201399.","journal-title":"J Alzheimers Dis"},{"key":"761_CR120","doi-asserted-by":"publisher","first-page":"11477","DOI":"10.1523\/JNEUROSCI.2816-08.2008","volume":"28","author":"JM Sontag","year":"2008","unstructured":"Sontag JM, Nunbhakdi-Craig V, Montgomery L, Arning E, Bottiglieri T, Sontag E. Folate deficiency induces in vitro and mouse brain region-specific downregulation of leucine carboxyl methyltransferase-1 and protein phosphatase 2A B(alpha) subunit expression that correlate with enhanced tau phosphorylation. J Neurosci. 2008;28:11477\u201387.","journal-title":"J Neurosci"},{"key":"761_CR121","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1523\/JNEUROSCI.3316-06.2007","volume":"27","author":"E Sontag","year":"2007","unstructured":"Sontag E, Nunbhakdi-Craig V, Sontag JM, Diaz-Arrastia R, Ogris E, Dayal S, Lentz SR, Arning E, Bottiglieri T. Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J Neurosci. 2007;27:2751\u20139.","journal-title":"J Neurosci"},{"key":"761_CR122","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fnagi.2014.00214","volume":"6","author":"JM Sontag","year":"2014","unstructured":"Sontag JM, Wasek B, Taleski G, Smith J, Arning E, Sontag E, Bottiglieri T. Altered protein phosphatase 2A methylation and Tau phosphorylation in the young and aged brain of methylenetetrahydrofolate reductase (MTHFR) deficient mice. Front Aging Neurosci. 2014;6:214.","journal-title":"Front Aging Neurosci"},{"key":"761_CR123","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41419-024-07179-3","volume":"15","author":"Y Yu","year":"2024","unstructured":"Yu Y, Chen CZ, Celardo I, Tan BWZ, Hurcomb JD, Leal NS, Popovic R, Loh SHY, Martins LM. Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer\u2019s disease models. Cell Death Dis. 2024;15:856.","journal-title":"Cell Death Dis"},{"key":"761_CR124","doi-asserted-by":"crossref","unstructured":"Zhang Z, Wu H, Qi S, Tang Y, Qin C, Liu R, Zhang J, Cao Y, Gao X. 5-methyltetrahydrofolate alleviates memory impairment in a rat model of Alzheimer\u2019s disease induced by D-galactose and aluminum chloride. Int J Environ Res Public Health. 2022;19:16426.","DOI":"10.3390\/ijerph192416426"},{"key":"761_CR125","doi-asserted-by":"publisher","first-page":"577843","DOI":"10.1016\/j.jneuroim.2022.577843","volume":"366","author":"A Alachkar","year":"2022","unstructured":"Alachkar A, Agrawal S, Baboldashtian M, Nuseir K, Salazar J, Agrawal A. L-methionine enhances neuroinflammation and impairs neurogenesis: Implication for Alzheimer\u2019s disease. J Neuroimmunol. 2022;366:577843.","journal-title":"J Neuroimmunol"},{"key":"761_CR126","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-015-0057-0","volume":"10","author":"C Tapia-Rojas","year":"2015","unstructured":"Tapia-Rojas C, Lindsay CB, Montecinos-Oliva C, Arrazola MS, Retamales RM, Bunout D, Hirsch S, Inestrosa NC. Is L-methionine a trigger factor for Alzheimer\u2019s-like neurodegeneration? Changes in Abeta oligomers, tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type mice. Mol Neurodegener. 2015;10:62.","journal-title":"Mol Neurodegener"},{"key":"761_CR127","doi-asserted-by":"publisher","first-page":"6683318","DOI":"10.1155\/2021\/6683318","volume":"2021","author":"T Pi","year":"2021","unstructured":"Pi T, Wei S, Jiang Y, Shi JS. High Methionine Diet-Induced Alzheimer\u2019s Disease like Symptoms Are Accompanied by 5-Methylcytosine Elevated Levels in the Brain. Behav Neurol. 2021;2021:6683318.","journal-title":"Behav Neurol"},{"key":"761_CR128","doi-asserted-by":"publisher","first-page":"102595","DOI":"10.1016\/j.redox.2022.102595","volume":"59","author":"Y Xi","year":"2023","unstructured":"Xi Y, Zhang Y, Zhou Y, Liu Q, Chen X, Liu X, Grune T, Shi L, Hou M, Liu Z. Effects of methionine intake on cognitive function in mild cognitive impairment patients and APP\/PS1 Alzheimer\u2019s Disease model mice: Role of the cystathionine-beta-synthase\/H(2)S pathway. Redox Biol. 2023;59:102595.","journal-title":"Redox Biol"},{"key":"761_CR129","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00401-022-02511-7","volume":"145","author":"YA Kim","year":"2023","unstructured":"Kim YA, Siddiqui T, Blaze J, Cosacak MI, Winters T, Kumar A, Tein E, Sproul AA, Teich AF, Bartolini F, et al. RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation. Acta Neuropathol. 2023;145:29\u201348.","journal-title":"Acta Neuropathol"},{"key":"761_CR130","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A. Epidemiology of Parkinson\u2019s disease. J Neural Transm (Vienna). 2017;124:901\u20135.","journal-title":"J Neural Transm (Vienna)"},{"key":"761_CR131","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 2006;5:525\u201335.","journal-title":"Lancet Neurol"},{"key":"761_CR132","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1126\/science.1098966","volume":"304","author":"JT Greenamyre","year":"2004","unstructured":"Greenamyre JT, Hastings TG. Biomedicine. Parkinson\u2019s\u2013divergent causes, convergent mechanisms. Science. 2004;304:1120\u20132.","journal-title":"Science"},{"key":"761_CR133","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0895-4356(01)00425-5","volume":"55","author":"A Elbaz","year":"2002","unstructured":"Elbaz A, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA. Risk tables for parkinsonism and Parkinson\u2019s disease. J Clin Epidemiol. 2002;55:25\u201331.","journal-title":"J Clin Epidemiol"},{"key":"761_CR134","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386:896\u2013912.","journal-title":"Lancet"},{"key":"761_CR135","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J. Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79:368\u201376.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"761_CR136","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL. Current understanding of the molecular mechanisms in Parkinson\u2019s disease: Targets for potential treatments. Transl Neurodegener. 2017;6:28.","journal-title":"Transl Neurodegener"},{"issue":"Pt 8","key":"761_CR137","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain. 1999;122(Pt 8):1437\u201348.","journal-title":"Brain"},{"key":"761_CR138","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13195-014-0073-2","volume":"6","author":"WS Kim","year":"2014","unstructured":"Kim WS, Kagedal K, Halliday GM. Alpha-synuclein biology in Lewy body diseases. Alzheimers Res Ther. 2014;6:73.","journal-title":"Alzheimers Res Ther"},{"key":"761_CR139","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","volume":"8","author":"SY Pang","year":"2019","unstructured":"Pang SY, Ho PW, Liu HF, Leung CT, Li L, Chang EES, Ramsden DB, Ho SL. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl Neurodegener. 2019;8:23.","journal-title":"Transl Neurodegener"},{"key":"761_CR140","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00441-018-2817-y","volume":"373","author":"KJ Billingsley","year":"2018","unstructured":"Billingsley KJ, Bandres-Ciga S, Saez-Atienzar S, Singleton AB. Genetic risk factors in Parkinson\u2019s disease. Cell Tissue Res. 2018;373:9\u201320.","journal-title":"Cell Tissue Res"},{"key":"761_CR141","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","volume":"1792","author":"H Jang","year":"2009","unstructured":"Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism. Biochim Biophys Acta. 2009;1792:714\u201321.","journal-title":"Biochim Biophys Acta"},{"key":"761_CR142","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/archneur.60.1.107","volume":"60","author":"BC Cree","year":"2003","unstructured":"Cree BC, Bernardini GL, Hays AP, Lowe G. A fatal case of coxsackievirus B4 meningoencephalitis. Arch Neurol. 2003;60:107\u201312.","journal-title":"Arch Neurol"},{"key":"761_CR143","doi-asserted-by":"publisher","first-page":"801","DOI":"10.4103\/aian.aian_539_23","volume":"26","author":"BV Maramattom","year":"2023","unstructured":"Maramattom BV, Philips G. Acute Parkinsonism with West Nile Virus Infection. Ann Indian Acad Neurol. 2023;26:801\u20133.","journal-title":"Ann Indian Acad Neurol"},{"key":"761_CR144","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/mds.870130413","volume":"13","author":"SM Mirsattari","year":"1998","unstructured":"Mirsattari SM, Power C, Nath A. Parkinsonism with HIV infection. Mov Disord. 1998;13:684\u20139.","journal-title":"Mov Disord"},{"key":"761_CR145","doi-asserted-by":"crossref","unstructured":"Nandipati S, Litvan I. Environmental exposures and Parkinson\u2019s disease. Int J Environ Res Public Health. 2016;13:881.","DOI":"10.3390\/ijerph13090881"},{"key":"761_CR146","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-212922","volume":"12","author":"BR De Miranda","year":"2022","unstructured":"De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER. Preventing Parkinson\u2019s Disease: An Environmental Agenda. J Parkinsons Dis. 2022;12:45\u201368.","journal-title":"J Parkinsons Dis"},{"key":"761_CR147","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnagi.2014.00036","volume":"6","author":"SE Seidl","year":"2014","unstructured":"Seidl SE, Santiago JA, Bilyk H, Potashkin JA. The emerging role of nutrition in Parkinson\u2019s disease. Front Aging Neurosci. 2014;6:36.","journal-title":"Front Aging Neurosci"},{"key":"761_CR148","doi-asserted-by":"crossref","unstructured":"Doddaballapur DB, Heyes DJ, Miyan JA. Multiple hits on cerebral folate, tetrahydrobiopterin and dopamine metabolism in the pathophysiology of Parkinson\u2019s disorder: a limited study of post-mortem human brain tissues. Metabolites. 2025;15:307.","DOI":"10.3390\/metabo15050307"},{"key":"761_CR149","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1017\/S0954422419000106","volume":"32","author":"LK Murray","year":"2019","unstructured":"Murray LK, Jadavji NM. The role of one-carbon metabolism and homocysteine in Parkinson\u2019s disease onset, pathology and mechanisms. Nutr Res Rev. 2019;32:218\u201330.","journal-title":"Nutr Res Rev"},{"key":"761_CR150","doi-asserted-by":"publisher","first-page":"18866","DOI":"10.1038\/s41598-025-03859-y","volume":"15","author":"C Zhang","year":"2025","unstructured":"Zhang C, Hu Y, Cao X, Deng Y, Wang Y, Guan M, Wu X, Jiang H. Lower water-soluble vitamins and higher homocysteine are associated with neurodegenerative diseases. Sci Rep. 2025;15:18866.","journal-title":"Sci Rep"},{"key":"761_CR151","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archneur.60.1.59","volume":"60","author":"JD Rogers","year":"2003","unstructured":"Rogers JD, Sanchez-Saffon A, Frol AB, Diaz-Arrastia R. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. Arch Neurol. 2003;60:59\u201364.","journal-title":"Arch Neurol"},{"key":"761_CR152","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/clinchem\/47.6.1102","volume":"47","author":"F Blandini","year":"2001","unstructured":"Blandini F, Fancellu R, Martignoni E, Mangiagalli A, Pacchetti C, Samuele A, Nappi G. Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease. Clin Chem. 2001;47:1102\u20134.","journal-title":"Clin Chem"},{"key":"761_CR153","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1002\/acn3.51227","volume":"7","author":"X Fan","year":"2020","unstructured":"Fan X, Zhang L, Li H, Chen G, Qi G, Ma X, Jin Y. Role of homocysteine in the development and progression of Parkinson\u2019s disease. Ann Clin Transl Neurol. 2020;7:2332\u20138.","journal-title":"Ann Clin Transl Neurol"},{"key":"761_CR154","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/archneur.61.6.865","volume":"61","author":"PE O\u2019Suilleabhain","year":"2004","unstructured":"O\u2019Suilleabhain PE, Sung V, Hernandez C, Lacritz L, Dewey RB Jr., Bottiglieri T, Diaz-Arrastia R. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations. Arch Neurol. 2004;61:865\u20138.","journal-title":"Arch Neurol"},{"key":"761_CR155","doi-asserted-by":"publisher","first-page":"1434943","DOI":"10.3389\/fnagi.2024.1434943","volume":"16","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Gan LH, Liang XN, Xu ZH, Hu TY, Li XY, Tang YL, Wang J, Liu YQ. Association of plasma homocysteine with cognitive impairment in patients with Parkinson\u2019s disease. Front Aging Neurosci. 2024;16:1434943.","journal-title":"Front Aging Neurosci"},{"key":"761_CR156","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00415-022-11361-y","volume":"270","author":"MT Perinan","year":"2023","unstructured":"Perinan MT, Macias-Garcia D, Jesus S, Martin-Rodriguez JF, Munoz-Delgado L, Jimenez-Jaraba MV, Buiza-Rueda D, Bonilla-Toribio M, Adarmes-Gomez AD, Gomez-Garre P, et al. Homocysteine levels, genetic background, and cognitive impairment in Parkinson\u2019s disease. J Neurol. 2023;270:477\u201385.","journal-title":"J Neurol"},{"key":"761_CR157","first-page":"3124295","volume":"2019","author":"MC Bakeberg","year":"2019","unstructured":"Bakeberg MC, Jefferson A, Riley M, Byrnes M, Ghosh S, Mastaglia FL, Horne MK, McGregor S, Stell R, Kenna J, et al. Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson\u2019s Disease. Parkinsons Dis. 2019;2019:3124295.","journal-title":"Parkinsons Dis"},{"key":"761_CR158","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/aian.AIAN_194_18","volume":"22","author":"TB Udagedara","year":"2019","unstructured":"Udagedara TB, Dhananjalee Alahakoon AM, Goonaratna IK. Vascular Parkinsonism: A Review on Management updates. Ann Indian Acad Neurol. 2019;22:17\u201320.","journal-title":"Ann Indian Acad Neurol"},{"key":"761_CR159","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1515\/med-2019-0069","volume":"14","author":"HM Diao","year":"2019","unstructured":"Diao HM, Song ZF, Xu HD. Association Between MTHFR Genetic Polymorphism and Parkinson\u2019s Disease Susceptibility: A Meta-analysis. Open Med (Wars). 2019;14:613\u201324.","journal-title":"Open Med (Wars)"},{"key":"761_CR160","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41531-021-00157-y","volume":"7","author":"E Romero-Gutierrez","year":"2021","unstructured":"Romero-Gutierrez E, Vazquez-Cardenas P, Moreno-Macias H, Salas-Pacheco J, Tusie-Luna T, Arias-Carrion O. Differences in MTHFR and LRRK2 variant\u2019s association with sporadic Parkinson\u2019s disease in Mexican Mestizos correlated to Native American ancestry. NPJ Parkinsons Dis. 2021;7:13.","journal-title":"NPJ Parkinsons Dis"},{"key":"761_CR161","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.cca.2010.11.004","volume":"412","author":"CS Fong","year":"2011","unstructured":"Fong CS, Shyu HY, Shieh JC, Fu YP, Chin TY, Wang HW, Cheng CW. Association of MTHFR, MTR, and MTRR polymorphisms with Parkinson\u2019s disease among ethnic Chinese in Taiwan. Clin Chim Acta. 2011;412:332\u20138.","journal-title":"Clin Chim Acta"},{"key":"761_CR162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2014.03.044","volume":"568","author":"N Kumudini","year":"2014","unstructured":"Kumudini N, Uma A, Naushad SM, Mridula R, Borgohain R, Kutala VK. Association of seven functional polymorphisms of one-carbon metabolic pathway with total plasma homocysteine levels and susceptibility to Parkinson\u2019s disease among South Indians. Neurosci Lett. 2014;568:1\u20135.","journal-title":"Neurosci Lett"},{"key":"761_CR163","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/JPD-130186","volume":"3","author":"D Salat","year":"2013","unstructured":"Salat D, Tolosa E. Levodopa in the treatment of Parkinson\u2019s disease: current status and new developments. J Parkinsons Dis. 2013;3:255\u201369.","journal-title":"J Parkinsons Dis"},{"key":"761_CR164","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1515\/CCLM.2006.143","volume":"44","author":"S Zoccolella","year":"2006","unstructured":"Zoccolella S, Lamberti P, Iliceto G, Dell\u2019Aquila C, Diroma C, Fraddosio A, Lamberti SV, Armenise E, Defazio G, de Mari M, et al. Elevated plasma homocysteine levels in L-dopa-treated Parkinson\u2019s disease patients with dyskinesias. Clin Chem Lab Med. 2006;44:863\u20136.","journal-title":"Clin Chem Lab Med"},{"key":"761_CR165","doi-asserted-by":"publisher","first-page":"105357","DOI":"10.1016\/j.parkreldis.2023.105357","volume":"109","author":"JE Ahlskog","year":"2023","unstructured":"Ahlskog JE. Levodopa, homocysteine and Parkinson\u2019s disease: What\u2019s the problem? Parkinsonism Relat Disord. 2023;109:105357.","journal-title":"Parkinsonism Relat Disord"},{"key":"761_CR166","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jocn.2021.03.047","volume":"88","author":"C Anamnart","year":"2021","unstructured":"Anamnart C, Kitjarak R. Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson\u2019s disease patients: A randomized controlled study. J Clin Neurosci. 2021;88:226\u201331.","journal-title":"J Clin Neurosci"},{"key":"761_CR167","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000333790","volume":"10","author":"J DiFrancisco-Donoghue","year":"2012","unstructured":"DiFrancisco-Donoghue J, Lamberg EM, Rabin E, Elokda A, Fazzini E, Werner WG. Effects of exercise and B vitamins on homocysteine and glutathione in Parkinson\u2019s disease: a randomized trial. Neurodegener Dis. 2012;10:127\u201334.","journal-title":"Neurodegener Dis"},{"key":"761_CR168","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, et al. Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect. 2011;119:866\u201372.","journal-title":"Environ Health Perspect"},{"key":"761_CR169","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0168-0102(03)00163-9","volume":"46","author":"K Shimizu","year":"2003","unstructured":"Shimizu K, Matsubara K, Ohtaki K, Shiono H. Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture. Neurosci Res. 2003;46:523\u201332.","journal-title":"Neurosci Res"},{"key":"761_CR170","doi-asserted-by":"publisher","first-page":"105932","DOI":"10.1016\/j.parkreldis.2023.105932","volume":"119","author":"P Sharma","year":"2024","unstructured":"Sharma P, Mittal P. Paraquat (herbicide) as a cause of Parkinson\u2019s Disease. Parkinsonism Relat Disord. 2024;119:105932.","journal-title":"Parkinsonism Relat Disord"},{"key":"761_CR171","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/toxsci\/kfz034","volume":"169","author":"NM Jadavji","year":"2019","unstructured":"Jadavji NM, Murray LK, Emmerson JT, Rudyk CA, Hayley S, Smith PD. Paraquat Exposure Increases Oxidative Stress Within the Dorsal Striatum of Male Mice With a Genetic Deficiency in One-carbon Metabolism. Toxicol Sci. 2019;169:25\u201333.","journal-title":"Toxicol Sci"},{"key":"761_CR172","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.neuro.2005.01.008","volume":"26","author":"ES Lee","year":"2005","unstructured":"Lee ES, Chen H, Soliman KF, Charlton CG. Effects of homocysteine on the dopaminergic system and behavior in rodents. Neurotoxicology. 2005;26:361\u201371.","journal-title":"Neurotoxicology"},{"key":"761_CR173","first-page":"47","volume":"6","author":"N Bhattacharjee","year":"2016","unstructured":"Bhattacharjee N, Paul R, Giri A, Borah A. Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinson\u2019s disease. Biochem Biophys Rep. 2016;6:47\u201353.","journal-title":"Biochem Biophys Rep"},{"key":"761_CR174","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1021\/acs.jafc.3c06337","volume":"72","author":"Y Jia","year":"2024","unstructured":"Jia Y, Li J, Wang Y, Ma Y, Chen L, Zhang H, Xue M, Liang H. Folic Acid Rescues Dopaminergic Neurons in MPTP-Induced Mice by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment. J Agric Food Chem. 2024;72:5734\u201345.","journal-title":"J Agric Food Chem"},{"key":"761_CR175","doi-asserted-by":"crossref","unstructured":"Houlihan KL, Keoseyan PP, Juba AN, Margaryan T, Voss ME, Babaoghli AM, Norris JM, Adrian GJ, Tovmasyan A, Buhlman LM. Folic acid improves Parkin-null drosophila phenotypes and transiently reduces vulnerable dopaminergic neuron mitochondrial hydrogen peroxide levels and glutathione redox equilibrium. Antioxid (Basel). 2022;11:2068.","DOI":"10.3390\/antiox11102068"},{"key":"761_CR176","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1007\/s11064-015-1598-x","volume":"40","author":"S Srivastav","year":"2015","unstructured":"Srivastav S, Singh SK, Yadav AK, Srikrishna S. Folic Acid Supplementation Ameliorates Oxidative Stress, Metabolic Functions and Developmental Anomalies in a Novel Fly Model of Parkinson\u2019s Disease. Neurochem Res. 2015;40:1350\u20139.","journal-title":"Neurochem Res"},{"key":"761_CR177","doi-asserted-by":"publisher","first-page":"fcac145","DOI":"10.1093\/braincomms\/fcac145","volume":"4","author":"P Gosset","year":"2022","unstructured":"Gosset P, Camu W, Raoul C, Mezghrani A. Prionoids in amyotrophic lateral sclerosis. Brain Commun. 2022;4:fcac145.","journal-title":"Brain Commun"},{"key":"761_CR178","doi-asserted-by":"crossref","unstructured":"Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med. 2017;7:a024117.","DOI":"10.1101\/cshperspect.a024117"},{"key":"761_CR179","unstructured":"Brotman RG, Moreno-Escobar MC, Joseph J, Munakomi S, Pawar G. Amyotrophic Lateral Sclerosis. In StatPearls, Treasure Island (FL), 2025."},{"key":"761_CR180","doi-asserted-by":"publisher","first-page":"e200109","DOI":"10.1212\/NXG.0000000000200109","volume":"9","author":"J Barberio","year":"2023","unstructured":"Barberio J, Lally C, Kupelian V, Hardiman O, Flanders WD. Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis. Neurol Genet. 2023;9:e200109.","journal-title":"Neurol Genet"},{"key":"761_CR181","doi-asserted-by":"crossref","unstructured":"Sabetta E, Ferrari D, Massimo L, Koks S. Tandem repeat expansions and copy number variations as risk factors and diagnostic tools for amyotrophic lateral sclerosis. Front Neurol. 2025;16:1522445.","DOI":"10.3389\/fneur.2025.1522445"},{"key":"761_CR182","first-page":"181","volume":"7","author":"C Ingre","year":"2015","unstructured":"Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181\u201393.","journal-title":"Clin Epidemiol"},{"key":"761_CR183","doi-asserted-by":"crossref","unstructured":"Goncharova PS, Davydova TK, Popova TE, Novitsky MA, Petrova MM, Gavrilyuk OA, Al-Zamil M, Zhukova NG, Nasyrova RF, Shnayder NA. Nutrient effects on motor neurons and the risk of amyotrophic lateral sclerosis. Nutrients. 2021;13:3804.","DOI":"10.3390\/nu13113804"},{"key":"761_CR184","doi-asserted-by":"crossref","unstructured":"Barros A, Felipe M, Barbosa IR, Leite-Lais L, Pedrosa LFC. Dietary intake of micronutrients and disease severity in patients with amyotrophic lateral sclerosis. Metabolites. 2023;13:696.","DOI":"10.3390\/metabo13060696"},{"key":"761_CR185","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s10072-022-06518-6","volume":"44","author":"N Hu","year":"2023","unstructured":"Hu N, Wang X. The level of homocysteine in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Neurol Sci. 2023;44:1185\u201392.","journal-title":"Neurol Sci"},{"key":"761_CR186","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1212\/01.wnl.0000297193.53986.6f","volume":"70","author":"S Zoccolella","year":"2008","unstructured":"Zoccolella S, Simone IL, Lamberti P, Samarelli V, Tortelli R, Serlenga L, Logroscino G. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis. Neurology. 2008;70:222\u20135.","journal-title":"Neurology"},{"key":"761_CR187","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/WCO.0000000000001311","volume":"37","author":"R Kaji","year":"2024","unstructured":"Kaji R, Izumi Y, Oki R. Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis. Curr Opin Neurol. 2024;37:593\u2013602.","journal-title":"Curr Opin Neurol"},{"key":"761_CR188","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1775::AID-MUS22>3.0.CO;2-V","volume":"21","author":"R Kaji","year":"1998","unstructured":"Kaji R, Kodama M, Imamura A, Hashida T, Kohara N, Ishizu M, Inui K, Kimura J. Effect of ultrahigh-dose methylcobalamin on compound muscle action potentials in amyotrophic lateral sclerosis: a double-blind controlled study. Muscle Nerve. 1998;21:1775\u20138.","journal-title":"Muscle Nerve"},{"key":"761_CR189","doi-asserted-by":"publisher","unstructured":"Hu N, Ding J, Tian H, Shen D, Yang X, Niu J, Liu M, Cui L. Impacts of oral supplementation of vitamin B12 and plasma levels of homocysteine on progression and survival in a Chinese ALS cohort. Neurol Res. 2025;1\u20139. https:\/\/doi.org\/10.1080\/01616412.2025.2553147.","DOI":"10.1080\/01616412.2025.2553147"},{"key":"761_CR190","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pjnns.2017.01.008","volume":"51","author":"K Zur-Wyrozumska","year":"2017","unstructured":"Zur-Wyrozumska K, Pera J, Dziubek A, Sado M, Golenia A, Slowik A, Dziedzic T. Association between C677T polymorphism of MTHFR gene and risk of amyotrophic lateral sclerosis: Polish population study and a meta-analysis. Neurol Neurochir Pol. 2017;51:135\u20139.","journal-title":"Neurol Neurochir Pol"},{"key":"761_CR191","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/jcb.30208","volume":"123","author":"NS de Lima","year":"2022","unstructured":"de Lima NS, da Costa CCP, Assuncao LDP, Santos KF, Bento D, da Silva Reis AA, Santos RDS. One-carbon metabolism pathway genes and their non-association with the development of amyotrophic lateral sclerosis. J Cell Biochem. 2022;123:620\u20137.","journal-title":"J Cell Biochem"},{"key":"761_CR192","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jns.2010.02.024","volume":"293","author":"X Zhang","year":"2010","unstructured":"Zhang X, Chen S, Li L, Wang Q, Le W. Decreased level of 5-methyltetrahydrofolate: a potential biomarker for pre-symptomatic amyotrophic lateral sclerosis. J Neurol Sci. 2010;293:102\u20135.","journal-title":"J Neurol Sci"},{"key":"761_CR193","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.neuropharm.2008.02.020","volume":"54","author":"X Zhang","year":"2008","unstructured":"Zhang X, Chen S, Li L, Wang Q, Le W. Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1 G93A transgenic mice. Neuropharmacology. 2008;54:1112\u20139.","journal-title":"Neuropharmacology"},{"key":"761_CR194","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA. Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis. 2010;5:40.","journal-title":"Orphanet J Rare Dis"},{"key":"761_CR195","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. Lancet. 2007;369:218\u201328.","journal-title":"Lancet"},{"key":"761_CR196","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1093\/nar\/gnf082","volume":"30","author":"E Moncke-Buchner","year":"2002","unstructured":"Moncke-Buchner E, Reich S, Mucke M, Reuter M, Messer W, Wanker EE, Kruger DH. Counting CAG repeats in the Huntington\u2019s disease gene by restriction endonuclease EcoP15I cleavage. Nucleic Acids Res. 2002;30:e83.","journal-title":"Nucleic Acids Res"},{"key":"761_CR197","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ajhg.2021.12.002","volume":"109","author":"DR Langbehn","year":"2022","unstructured":"Langbehn DR, Registry Investigators of the European Huntington Disease N. Longer CAG repeat length is associated with shorter survival after disease onset in Huntington disease. Am J Hum Genet. 2022;109:172\u20139.","journal-title":"Am J Hum Genet"},{"key":"761_CR198","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR. International Huntington\u2019s Disease Collaborative G. A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin Genet. 2004;65:267\u201377.","journal-title":"Clin Genet"},{"key":"761_CR199","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3892\/etm.2016.3566","volume":"12","author":"WJ Huang","year":"2016","unstructured":"Huang WJ, Chen WW, Zhang X. Huntington\u2019s disease: Molecular basis of pathology and status of current therapeutic approaches. Exp Ther Med. 2016;12:1951\u20136.","journal-title":"Exp Ther Med"},{"key":"761_CR200","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neubiorev.2015.03.003","volume":"52","author":"C Mo","year":"2015","unstructured":"Mo C, Hannan AJ, Renoir T. Environmental factors as modulators of neurodegeneration: insights from gene-environment interactions in Huntington\u2019s disease. Neurosci Biobehav Rev. 2015;52:178\u201392.","journal-title":"Neurosci Biobehav Rev"},{"key":"761_CR201","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/mds.23108","volume":"25","author":"MK Trembath","year":"2010","unstructured":"Trembath MK, Horton ZA, Tippett L, Hogg V, Collins VR, Churchyard A, Velakoulis D, Roxburgh R, Delatycki MB. A retrospective study of the impact of lifestyle on age at onset of Huntington disease. Mov Disord. 2010;25:1444\u201350.","journal-title":"Mov Disord"},{"key":"761_CR202","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/hmg\/7.3.371","volume":"7","author":"JM Boutell","year":"1998","unstructured":"Boutell JM, Wood JD, Harper PS, Jones AL. Huntingtin interacts with cystathionine beta-synthase. Hum Mol Genet. 1998;7:371\u20138.","journal-title":"Hum Mol Genet"},{"key":"761_CR203","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1515\/pteridines.2002.13.4.121","volume":"13","author":"A Laich","year":"2002","unstructured":"Laich A, Leblhuber F, Widner B, Frick B, Jellinger K, Fuchs D. Moderate Hyperhomocysteinemia in Patients with Huntington\u2019s Disease. Pteridines. 2002;13:121\u20135.","journal-title":"Pteridines"},{"key":"761_CR204","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/mds.10629","volume":"19","author":"J Andrich","year":"2004","unstructured":"Andrich J, Saft C, Arz A, Schneider B, Agelink MW, Kraus PH, Kuhn W, Muller T. Hyperhomocysteinaemia in treated patients with Huntington\u2019s disease homocysteine in HD. Mov Disord. 2004;19:226\u20138.","journal-title":"Mov Disord"},{"key":"761_CR205","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00018-022-04587-6","volume":"79","author":"CY Hung","year":"2022","unstructured":"Hung CY, Zhu C, Kittur FS, He M, Arning E, Zhang J, Johnson AJ, Jawa GS, Thomas MD, Ding TT, et al. A plant-based mutant huntingtin model-driven discovery of impaired expression of GTPCH and DHFR. Cell Mol Life Sci. 2022;79:553.","journal-title":"Cell Mol Life Sci"},{"key":"761_CR206","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s13205-023-03525-y","volume":"13","author":"SS Pradhan","year":"2023","unstructured":"Pradhan SS, Rao KR, Manjunath M, Saiswaroop R, Patnana DP, Phalguna KS, Choudhary B, Sivaramakrishnan V, Vitamin. B(6,) B(12) and folate modulate deregulated pathways and protein aggregation in yeast model of Huntington disease. 3 Biotech. 2023;13:96.","journal-title":"3 Biotech"},{"key":"761_CR207","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41392-025-02415-4","volume":"10","author":"I Boutitah-Benyaich","year":"2025","unstructured":"Boutitah-Benyaich I, Eixarch H, Villacieros-Alvarez J, Hervera A, Cobo-Calvo A, Montalban X, Espejo C. Multiple sclerosis: molecular pathogenesis and therapeutic intervention. Signal Transduct Target Ther. 2025;10:324.","journal-title":"Signal Transduct Target Ther"},{"key":"761_CR208","doi-asserted-by":"publisher","first-page":"e214141","DOI":"10.1212\/WNL.0000000000214141","volume":"105","author":"N Sahi","year":"2025","unstructured":"Sahi N, Ciccarelli O, Houlden H, Chard DT. Unlocking Multiple Sclerosis Genetics: From Susceptibility to Severity. Neurology. 2025;105:e214141.","journal-title":"Neurology"},{"key":"761_CR209","unstructured":"Tafti D, Ehsan M, Xixis KL. Multiple sclerosis. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499849\/."},{"key":"761_CR210","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2174\/187152712801661220","volume":"11","author":"JO Virtanen","year":"2012","unstructured":"Virtanen JO, Jacobson S. Viruses and multiple sclerosis. CNS Neurol Disord Drug Targets. 2012;11:528\u201344.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"761_CR211","first-page":"160","volume":"19","author":"K Bjornevik","year":"2023","unstructured":"Bjornevik K, Munz C, Cohen JI, Ascherio A. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol. 2023;19:160\u201371.","journal-title":"Nat Rev Neurol"},{"key":"761_CR212","doi-asserted-by":"crossref","unstructured":"Mandato C, Colucci A, Lanzillo R, Staiano A, Scarpato E, Schiavo L, Operto FF, Serra MR, Di Monaco C, Napoli JS et al. Multiple sclerosis-related dietary and nutritional issues: an updated scoping review with a focus on pediatrics. Child (Basel). 2023;10:1022.","DOI":"10.3390\/children10061022"},{"key":"761_CR213","doi-asserted-by":"publisher","first-page":"751","DOI":"10.7150\/ijms.42058","volume":"17","author":"X Li","year":"2020","unstructured":"Li X, Yuan J, Han J, Hu W. Serum levels of Homocysteine, Vitamin B12 and Folate in Patients with Multiple Sclerosis: an Updated Meta-Analysis. Int J Med Sci. 2020;17:751\u201361.","journal-title":"Int J Med Sci"},{"key":"761_CR214","doi-asserted-by":"publisher","first-page":"106711","DOI":"10.1016\/j.msard.2025.106711","volume":"103","author":"CM Ribeiro","year":"2025","unstructured":"Ribeiro CM, Oliveira SR, Alfieri DF, Lozovoy MAB, Simao ANC, Reiche EMV. Methylenetetrahydrofolate reductase (MTHFR) 677C\u2009>\u2009T rs1801133 genetic variant, homocysteine, folate, and vitamin B12 levels in patients with multiple sclerosis: a scoping review. Mult Scler Relat Disord. 2025;103:106711.","journal-title":"Mult Scler Relat Disord"},{"key":"761_CR215","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jocn.2010.12.022","volume":"18","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, He ZY, Liu HN. Meta-analysis of the relationship between homocysteine, vitamin B(1)(2), folate, and multiple sclerosis. J Clin Neurosci. 2011;18:933\u20138.","journal-title":"J Clin Neurosci"},{"key":"761_CR216","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1134\/S0006297924030143","volume":"89","author":"VI Lioudyno","year":"2024","unstructured":"Lioudyno VI, Tsymbalova EA, Chernyavskaya EA, Scripchenko EY, Bisaga GN, Dmitriev AV, Abdurasulova IN. Association of Increased Homocysteine Levels with Impaired Folate Metabolism and Vitamin B Deficiency in Early-Onset Multiple Sclerosis. Biochem (Mosc). 2024;89:562\u201373.","journal-title":"Biochem (Mosc)"},{"key":"761_CR217","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00415-007-0668-7","volume":"255","author":"C Russo","year":"2008","unstructured":"Russo C, Morabito F, Luise F, Piromalli A, Battaglia L, Vinci A, Trapani Lombardo V, de Marco V, Morabito P, Condino F, et al. Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis. J Neurol. 2008;255:64\u20139.","journal-title":"J Neurol"},{"key":"761_CR218","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neuroscience.2025.07.046","volume":"583","author":"H Abbasi","year":"2025","unstructured":"Abbasi H, Allogmanny S, Khoshdooz S, Asgarzade A, Probst Y. Exploring the Link of Serum Vitamin B12, Folate, and Homocysteine Concentrations in Individuals with Multiple Sclerosis: An Umbrella Meta-analysis of Case-control Studies. Neuroscience. 2025;583:179\u201386.","journal-title":"Neuroscience"},{"key":"761_CR219","doi-asserted-by":"publisher","first-page":"105883","DOI":"10.1016\/j.msard.2024.105883","volume":"91","author":"CM Ribeiro","year":"2024","unstructured":"Ribeiro CM, Oliveira SR, Flauzino T, Alfieri DF, Simao ANC, Lozovoy MAB, Maes M, Reiche EMV. The effects of the MTHFR 677C\u2009>\u2009T (rs1801133) genetic variant on susceptibility and disability worsening in multiple sclerosis patients are mediated by homocysteine. Mult Scler Relat Disord. 2024;91:105883.","journal-title":"Mult Scler Relat Disord"},{"key":"761_CR220","doi-asserted-by":"publisher","first-page":"103255","DOI":"10.1016\/j.msard.2021.103255","volume":"56","author":"H Peng","year":"2021","unstructured":"Peng H, Wu X, Lin J, Guan W. Genetically predicted circulating homocysteine, vitamin B12, and folate levels and risk of multiple sclerosis: evidence from a two-sample Mendelian randomization analysis. Mult Scler Relat Disord. 2021;56:103255.","journal-title":"Mult Scler Relat Disord"},{"key":"761_CR221","doi-asserted-by":"publisher","first-page":"e1501678","DOI":"10.1126\/sciadv.1501678","volume":"2","author":"TF Andlauer","year":"2016","unstructured":"Andlauer TF, Buck D, Antony G, Bayas A, Bechmann L, Berthele A, Chan A, Gasperi C, Gold R, Graetz C, et al. Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Sci Adv. 2016;2:e1501678.","journal-title":"Sci Adv"},{"key":"761_CR222","doi-asserted-by":"publisher","first-page":"4568145","DOI":"10.1155\/2022\/4568145","volume":"2022","author":"M Lu","year":"2022","unstructured":"Lu M, Peng K, Song L, Luo L, Liang P, Liang Y. Association between Genetic Polymorphisms in Methylenetetrahydrofolate Reductase and Risk of Autoimmune Diseases: A Systematic Review and Meta-Analysis. Dis Markers. 2022;2022:4568145.","journal-title":"Dis Markers"},{"key":"761_CR223","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/01616412.2024.2337519","volume":"46","author":"AE Asci","year":"2024","unstructured":"Asci AE, Orhan G, Karahalil B. Genetic variants of folate metabolism and the risk of multiple sclerosis. Neurol Res. 2024;46:544\u201352.","journal-title":"Neurol Res"},{"key":"761_CR224","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neulet.2014.01.008","volume":"562","author":"BV Ineichen","year":"2014","unstructured":"Ineichen BV, Keskitalo S, Farkas M, Bain N, Kallweit U, Weller M, Klotz L, Linnebank M. Genetic variants of homocysteine metabolism and multiple sclerosis: a case-control study. Neurosci Lett. 2014;562:75\u20138.","journal-title":"Neurosci Lett"},{"key":"761_CR225","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7762\/cnr.2019.8.1.36","volume":"8","author":"E Nozari","year":"2019","unstructured":"Nozari E, Ghavamzadeh S, Razazian N. The Effect of Vitamin B12 and Folic Acid Supplementation on Serum Homocysteine, Anemia Status and Quality of Life of Patients with Multiple Sclerosis. Clin Nutr Res. 2019;8:36\u201345.","journal-title":"Clin Nutr Res"},{"key":"761_CR226","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1136\/jnnp.54.12.1055","volume":"54","author":"WH Likosky","year":"1991","unstructured":"Likosky WH, Fireman B, Elmore R, Eno G, Gale K, Goode GB, Ikeda K, Laster J, Mosher C, Rozance J, et al. Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study. J Neurol Neurosurg Psychiatry. 1991;54:1055\u201360.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"761_CR227","doi-asserted-by":"publisher","first-page":"1410745","DOI":"10.3389\/fnut.2024.1410745","volume":"11","author":"H Nan","year":"2024","unstructured":"Nan H. Causal effects of dietary composition on multiple sclerosis risk and severity: a Mendelian randomization study. Front Nutr. 2024;11:1410745.","journal-title":"Front Nutr"},{"key":"761_CR228","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ajpath.2013.04.030","volume":"183","author":"AS Paintlia","year":"2013","unstructured":"Paintlia AS, Paintlia MK, Mohan S, Singh AK, Singh I. AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model. Am J Pathol. 2013;183:526\u201341.","journal-title":"Am J Pathol"},{"key":"761_CR229","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12974-021-02073-7","volume":"18","author":"P Elo","year":"2021","unstructured":"Elo P, Li XG, Liljenback H, Gardberg M, Moisio O, Miner M, Virta J, Saraste A, Srinivasarao M, Pugh M, et al. Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis. J Neuroinflammation. 2021;18:30.","journal-title":"J Neuroinflammation"},{"key":"761_CR230","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12974-019-1612-3","volume":"16","author":"P Elo","year":"2019","unstructured":"Elo P, Li XG, Liljenback H, Helin S, Teuho J, Koskensalo K, Saunavaara V, Marjamaki P, Oikonen V, Virta J, et al. Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats. J Neuroinflammation. 2019;16:252.","journal-title":"J Neuroinflammation"},{"key":"761_CR231","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3945\/ajcn.116.139030","volume":"104","author":"H Sawaengsri","year":"2016","unstructured":"Sawaengsri H, Bergethon PR, Qiu WQ, Scott TM, Jacques PF, Selhub J, Paul L. Transcobalamin 776C\u2013>G polymorphism is associated with peripheral neuropathy in elderly individuals with high folate intake. Am J Clin Nutr. 2016;104:1665\u201370.","journal-title":"Am J Clin Nutr"},{"key":"761_CR232","doi-asserted-by":"crossref","unstructured":"Fardous AM, Heydari AR. Uncovering the hidden dangers and molecular mechanisms of excess folate: a narrative review. Nutrients. 2023;15:4699.","DOI":"10.3390\/nu15214699"}],"container-title":["Current Nutrition Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-026-00761-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13668-026-00761-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-026-00761-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:47:46Z","timestamp":1781650066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13668-026-00761-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":232,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["761"],"URL":"https:\/\/doi.org\/10.1007\/s13668-026-00761-5","relation":{},"ISSN":["2161-3311"],"issn-type":[{"value":"2161-3311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}